Tools
Tools
Wauquier, Fabien, Boutin-Wittrant, Line, Pourtau, Line, Gaudout, David, Moras, Benjamin, Vignault, Adeline, Monchaux De Oliveira, Camille, Gabaston, Julien, Vaysse, Carole, Bertrand, Karène, Abrous, Hélène, Capuron, Lucile, Castanon, Nathalie, Vauzour, David 
ORCID: https://orcid.org/0000-0001-5952-8756, Roux, Véronique, Macian, Nicolas, Pickering, Gisèle and Wittrant, Yohann
(2022)
Circulating human serum metabolites derived from the intake of a saffron extract (Safr’Inside™) protect neurons from oxidative stress: Consideration for depressive disorders.
Nutrients, 14 (7).
ISSN 2072-6643
Preview |
PDF (nutrients-14-01511)
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Increases in oxidative stress have been reported to play a central role in the vulnerability to depression, and antidepressant drugs may reduce increased oxidative stress in patients. Among the plants exerting anti-inflammatory and anti-oxidant properties, saffron, a spice derived from the flower of Crocus sativus, is also known for its positive effects on depression, potentially through its SSRI-like properties. However, the molecular mechanisms underlying these effects and their health benefits for humans are currently unclear. Using an original ex vivo clinical approach, we demonstrated for the first time that the circulating human metabolites produced following saffron intake (Safr’Inside™ ) protect human neurons from oxidative-stress-induced neurotoxicity by preserving cell viability and increasing BNDF production. In particular, the metabolites significantly stimulated both dopamine and serotonin release. In addition, the saffron’s metabolites were also able to protect serotonergic tone by inhibiting the expression of the serotonin transporter SERT and down-regulating serotonin metabolism. Altogether, these data provide new biochemical insights into the mechanisms underlying the beneficial impact of saffron on neuronal viability and activity in humans, in the context of oxidative stress related to depression.
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Information: This project was funded by Activ’Inside and supported by Nouvelle Aquitaine Regional Council in the framework of the “SilverPhytoNutrients” project. The contribution of Y.W. was supported by INRAE. The contribution of PIC/CIC (V.R., N.M. and G.P.) was supported by INSERM and University Hospital. |
| Uncontrolled Keywords: | bdnf,brain,clinical trial,crocetin,depression,dopamine,mental health,serotonin,sert,sh-sy5y,food science,nutrition and dietetics,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/1100/1106 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Centres > Norwich Institute for Healthy Aging Faculty of Medicine and Health Sciences > Research Groups > Nutrition and Preventive Medicine Faculty of Medicine and Health Sciences > Research Centres > Lifespan Health Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 08 Apr 2022 10:30 |
| Last Modified: | 06 Jun 2024 15:17 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/84526 |
| DOI: | 10.3390/nu14071511 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |